Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus granulosus | survival motor neuron protein 1 | Get druggable targets OG5_132873 | All targets in OG5_132873 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_132873 | All targets in OG5_132873 |
Brugia malayi | hypothetical protein | Get druggable targets OG5_132873 | All targets in OG5_132873 |
Echinococcus multilocularis | survival motor neuron protein 1 | Get druggable targets OG5_132873 | All targets in OG5_132873 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0156 | 0.1266 | 0.4011 |
Trichomonas vaginalis | esterase, putative | 0.0156 | 0.1266 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0074 | 0.0411 | 0.0593 |
Mycobacterium ulcerans | hypothetical protein | 0.0156 | 0.1266 | 0.5 |
Onchocerca volvulus | 0.0156 | 0.1266 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0108 | 0.0766 | 0.2425 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0703 | 0.6929 | 1 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0156 | 0.1266 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.0339 | 0.3158 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0156 | 0.1266 | 0.5 |
Loa Loa (eye worm) | beta-lactamase | 0.0156 | 0.1266 | 0.4011 |
Echinococcus granulosus | tar DNA binding protein | 0.0339 | 0.3158 | 0.4557 |
Mycobacterium leprae | conserved hypothetical protein | 0.0156 | 0.1266 | 0.5 |
Brugia malayi | RNA binding protein | 0.0339 | 0.3158 | 1 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0156 | 0.1266 | 0.1828 |
Loa Loa (eye worm) | hypothetical protein | 0.0156 | 0.1266 | 0.4011 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0156 | 0.1266 | 0.4011 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 0.2605 | 0.376 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0156 | 0.1266 | 0.5 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0156 | 0.1266 | 0.5 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0156 | 0.1266 | 0.1828 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0156 | 0.1266 | 0.4011 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0156 | 0.1266 | 0.5 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 0.2605 | 0.376 |
Schistosoma mansoni | tar DNA-binding protein | 0.0339 | 0.3158 | 0.4557 |
Echinococcus multilocularis | tar DNA binding protein | 0.0339 | 0.3158 | 0.4557 |
Brugia malayi | beta-lactamase family protein | 0.0156 | 0.1266 | 0.4011 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0156 | 0.1266 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0108 | 0.0766 | 0.2425 |
Mycobacterium ulcerans | beta-lactamase | 0.0156 | 0.1266 | 0.5 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0703 | 0.6929 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0339 | 0.3158 | 1 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0703 | 0.6929 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0339 | 0.3158 | 1 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0156 | 0.1266 | 0.5 |
Toxoplasma gondii | ABC1 family protein | 0.0156 | 0.1266 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0108 | 0.0766 | 0.2425 |
Loa Loa (eye worm) | hypothetical protein | 0.0156 | 0.1266 | 0.4011 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0156 | 0.1266 | 0.1828 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0339 | 0.3158 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0156 | 0.1266 | 0.4011 |
Brugia malayi | beta-lactamase | 0.0156 | 0.1266 | 0.4011 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0156 | 0.1266 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0074 | 0.0411 | 0.1302 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0156 | 0.1266 | 0.5 |
Mycobacterium leprae | Probable lipase LipE | 0.0156 | 0.1266 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0339 | 0.3158 | 0.4557 |
Schistosoma mansoni | survival motor neuron protein | 0.0058 | 0.0249 | 0.036 |
Onchocerca volvulus | 0.0156 | 0.1266 | 1 | |
Schistosoma mansoni | tar DNA-binding protein | 0.0339 | 0.3158 | 0.4557 |
Leishmania major | hypothetical protein, conserved | 0.0156 | 0.1266 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.0249 | 0.036 |
Brugia malayi | hypothetical protein | 0.0286 | 0.2605 | 0.825 |
Brugia malayi | beta-lactamase family protein | 0.0156 | 0.1266 | 0.4011 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0156 | 0.1266 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0339 | 0.3158 | 0.4557 |
Loa Loa (eye worm) | hypothetical protein | 0.0156 | 0.1266 | 0.4011 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0156 | 0.1266 | 0.5 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0058 | 0.0249 | 0.0789 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0156 | 0.1266 | 0.1828 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0074 | 0.0411 | 0.1302 |
Onchocerca volvulus | 0.0156 | 0.1266 | 1 | |
Mycobacterium ulcerans | lipase LipD | 0.0156 | 0.1266 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0156 | 0.1266 | 0.4011 |
Brugia malayi | TAR-binding protein | 0.0339 | 0.3158 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.2605 | 0.825 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0108 | 0.0766 | 0.2425 |
Schistosoma mansoni | tar DNA-binding protein | 0.0339 | 0.3158 | 0.4557 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.1413 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 0.3162 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 4.6535 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 16.5113 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.